Status:
COMPLETED
Evaluation of the Treatment Response in Breast Cancer Related Lymphedema
Lead Sponsor:
Ege University
Conditions:
Lymphedema of Upper Limb
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate the effects of the treatment for breast cancer lymphedema. After taking a detailed history and giving a physical examination, breast cancer related lymphedema patients(n:30...
Eligibility Criteria
Inclusion
- Unilateral lymphedema of the arm after mastectomy for breast cancer
Exclusion
- Bilateral lymphedema
- Primary bone tumor and/or metastasis
- Patients with ongoing radiotherapy
- Circulation disorders of the upper extremity(eg; peripheral vascular disease, thrombosis)
- Patients with infectious lymphedema/elephantiasis
- Presence of local infection in upper extremities(cellulitis) and/or presence of severe systemic infection
- Carcinomatous lymphangitis
- Congestive heart failure(NYHA class 3 or 4)
- History of prosthesis on upper extremities
- Use of drugs which may alter the fluid or electrolyte balance
Key Trial Info
Start Date :
July 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04766489
Start Date
July 11 2019
End Date
December 11 2019
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University Faculty of Medicine
Izmir, Bornova, Turkey (Türkiye), 35100